PMID- 38451662 OWN - NLM STAT- MEDLINE DCOM- 20240308 LR - 20240308 IS - 1678-4219 (Electronic) IS - 0004-2803 (Linking) VI - 61 DP - 2024 TI - ACCURACY OF THE EOSINOPHILIC ESOPHAGITIS ENDOSCOPIC REFERENCE SCORE IN CHILDREN. PG - e23103 LID - S0004-28032024000100200 [pii] LID - 10.1590/S0004-2803.24612023-103 [doi] AB - BACKGROUND: To assess the efficacy of applying the endoscopic reference score for EoE (EREFS) in children with symptoms of esophageal dysfunction naive to proton pump inhibitor (PPI) therapy. METHODS: An observational cross-sectional study was conducted by reviewing reports and photographs of upper gastrointestinal endoscopies (UGE) and esophageal biopsies of patients with symptoms of esophageal dysfunction. Patients who were treated with PPI or had other conditions that may cause esophageal eosinophilia were excluded. RESULTS: Of the 2,036 patients evaluated, endoscopic findings of EoE were identified in 248 (12.2%) and more than one abnormality was observed in 167 (8.2%). Among all patients, 154 (7.6%) presented esophageal eosinophilia (>/=15 eosinophils per high power field) (P<0.01). In this group, 30 patients (19.5%) had normal endoscopy. In patients with EoE, edema (74% vs 6.5%, P<0.01) and furrows (66.2% vs 2.4%, P<0.01) were more prevalent than in the control group. Association of edema and furrows was more frequent in patients with EoE than in the control group (29.2% vs 1.6%, P<0.01, OR=24.7, CI=15.0-40.5). The presence of more than one endoscopic finding had sensitivity of 80.5%, specificity of 93.4%, positive predictive value (PPV) of 50%, negative predictive value (NPV) of 98.3%, and accuracy of 92.4%. CONCLUSION: In conclusion, this study showed that endoscopic features suggestive of EoE had high specificity and NPV for diagnosing EoE in children naive to PPI therapy. These findings highlight the importance of the EREFS in contributing to early identification of inflammatory and fibrostenosing characteristics of EoE, making it possible to identify and to avoid progression of the disease. BACKGROUND: * The EoE endoscopic reference score (EREFS) was developed and validated in adults and has been demonstrated to be an adequate tool for diagnosing and assessing treatment response in children. BACKGROUND: * The presence of more than one endoscopic finding stronglysuggests EoE. BACKGROUND: * The EoE endoscopic reference score presents high specificity and negative predictive value for diagnosing EoE in children naive to proton pump inhibitor (PPI) therapy. BACKGROUND: * Endoscopic findings suggestive of EoE in patients naive to treatment may be useful to characterize disease phenotype and individualize treatment according to the initial clinical presentation. FAU - Ribeiro, Luciana M AU - Ribeiro LM AUID- ORCID: 0000-0001-9643-2593 AD - Hospital Pequeno Principe, Centro de Gastroenterologia Pediatrica, Curitiba, PR, Brasil. AD - Pontificia Universidade Catolica do Parana, Faculdade de Medicina, Curitiba, PR, Brasil. FAU - Vieira, Mario C AU - Vieira MC AUID- ORCID: 0000-0003-3405-2995 AD - Hospital Pequeno Principe, Centro de Gastroenterologia Pediatrica, Curitiba, PR, Brasil. AD - Pontificia Universidade Catolica do Parana, Faculdade de Medicina, Curitiba, PR, Brasil. FAU - Truppel, Sabine K AU - Truppel SK AUID- ORCID: 0000-0001-9385-8310 AD - Hospital Pequeno Principe, Centro de Gastroenterologia Pediatrica, Curitiba, PR, Brasil. FAU - Rosario Filho, Nelson A AU - Rosario Filho NA AUID- ORCID: 0000-0002-8550-8051 AD - Universidade Federal do Parana, Departamento de Pediatria, Curitiba, PR, Brasil. LA - eng PT - Journal Article PT - Observational Study DEP - 20240304 PL - Brazil TA - Arq Gastroenterol JT - Arquivos de gastroenterologia JID - 15310600R RN - 0 (Proton Pump Inhibitors) RN - Eosinophilic enteropathy SB - IM MH - Child MH - Humans MH - Cross-Sectional Studies MH - Edema MH - Endoscopy MH - *Enteritis MH - *Eosinophilia MH - *Eosinophilic Esophagitis/diagnosis/drug therapy MH - *Gastritis MH - Proton Pump Inhibitors/therapeutic use EDAT- 2024/03/07 12:42 MHDA- 2024/03/08 06:43 CRDT- 2024/03/07 11:55 PHST- 2023/07/14 00:00 [received] PHST- 2023/10/06 00:00 [accepted] PHST- 2024/03/08 06:43 [medline] PHST- 2024/03/07 12:42 [pubmed] PHST- 2024/03/07 11:55 [entrez] AID - S0004-28032024000100200 [pii] AID - 10.1590/S0004-2803.24612023-103 [doi] PST - epublish SO - Arq Gastroenterol. 2024 Mar 4;61:e23103. doi: 10.1590/S0004-2803.24612023-103. eCollection 2024.